The landscape of viral expression and host gene fusion and adaptation in human cancer

Nature Communications

Volumn 4, Issue , 2013, Pages

  Tang, Ka Wei ^a   Alaei Mahabadi, Babak ^a   Samuelsson, Tore ^a   Lindh, Magnus ^a   Larsson, Erik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADAPTATION; CANCER; COHORT ANALYSIS; DATA ACQUISITION; DISEASE CONTROL; DISEASE TREATMENT; GENE EXPRESSION; GENOME; HUMAN GEOGRAPHY; VIRAL DISEASE;

ADAPTATION; ARTICLE; BLADDER CARCINOMA; BREAST; CANCER RISK; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COXSACKIE VIRUS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; GENE ACTIVITY; GENE DOSAGE; GENE EXPRESSION; GENE FUSION; GENE INSERTION; GENOMIC INSTABILITY; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 2; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 68B; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 6B; HUMAN PAPILLOMAVIRUS TYPE 70; IN SITU HYBRIDIZATION; INVASIVE CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POLYOMA VIRUS; RNA SEQUENCE; T LYMPHOCYTE; TRANSITIONAL CELL CARCINOMA; TUMOR VIRUS; UTERINE CERVIX CANCER; UTERUS CARCINOMA; VIRUS ETIOLOGY; VIRUS EXPRESSION; VIRUS GENE; VIRUS GENOME; VIRUS ONCOGENE; WART VIRUS;

ADAPTATION, BIOLOGICAL; CHROMOSOME MAPPING; DATABASES, GENETIC; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENOME, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOPLASMS; ONCOGENIC VIRUSES; RECEPTOR, ERBB-2; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME; TUMOR VIRUS INFECTIONS;

EID: 84885109819     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3513     Document Type: Article

References (47)

1. Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878-889 (2010).
2. Williams, R. Global challenges in liver disease. Hepatology 44, 521-526 (2006).
3. Strong, K., Mathers, C., Epping-Jordan, J., Resnikoff, S. & Ullrich, A. Preventing cancer through tobacco and infection control: How many lives can we save in the next 10 years? Eur. J. Cancer Prev. 17, 153-161 (2008).
4. Feng, H., Shuda, M., Chang, Y. & Moore, P. S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319, 1096-1100 (2008).
5. Arora, R., Chang, Y. & Moore, P. S. MCV and Merkel cell carcinoma: A molecular success story. Curr. Opin. Virol. 2, 489-498 (2012).
6. Isakov, O., Modai, S. & Shomron, N. Pathogen detection using short-rNA deep sequencing subtraction and assembly. Bioinformatics 27, 2027-2030 (2011).
7. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
8. Sung, W. K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 44, 765-769 (2012).
9. Jiang, Z. et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 22, 593-601 (2012).
10. Chen, Y. et al. VirusSeq: Software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue. Bioinformatics 29, 266-267 (2013).
11. Joshi, D. & Buehring, G. C. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res. Treat. 135, 1-15 (2012).
12. Dziurzynski, K. et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 14, 246-255 (2012).
13. Clifford, G., Franceschi, S., Diaz, M., Munoz, N. & Villa, L. L. Chapter 3: HPV type-Distribution in women with and without cervical neoplastic diseases. Vaccine 24(Suppl 3): S3/26-s3/34 (2006).
14. Mork, J. et al. Human papillomavirus infection as a risk factor for squamouscell carcinoma of the head and neck. N. Engl. J. Med. 344, 1125-1131 (2001).
15. Cheng, J. Y., Sheu, L. F., Meng, C. L., Lee, W. H. & Lin, J. C. Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut 37, 87-90 (1995).
16. Gornick, M. C. et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 21, 737-743 (2010).
17. Clifford, G. & Franceschi, S. Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int. J. Cancer 122, 1684-1685 (2008).
18. Bradrick, S. S., Walters, R. W. & Gromeier, M. The hepatitis C virus 30-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase. Nucleic Acids Res. 34, 1293-1303 (2006).
19. Kim, C. M., Koike, K., Saito, I., Miyamura, T. & Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317-320 (1991).
20. Abend, J. R., Jiang, M. & Imperiale, M. J. BK virus and human cancer: Innocent until proven guilty. Semin. Cancer Biol. 19, 252-260 (2009).
21. Fields, B. N., Knipe, D. M. & Howley, P. M. in Fields Virology 5th edn (Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007).
22. Larsson, P. A. et al. Reactivity against herpes simplex virus in patients with head and neck cancer. Int. J. Cancer 49, 14-18 (1991).
23. Hue, S. et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7, 111 (2010).
24. Peter, M. et al. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25, 5985-5993 (2006).
25. Schmitz, M., Driesch, C., Jansen, L., Runnebaum, I. B. & Durst, M. Nonrandom integration of the HPV genome in cervical cancer. PLoS One 7, e39632 (2012).
26. Wentzensen, N., Vinokurova, S. & von Knebel Doeberitz, M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64, 3878-3884 (2004).
27. Narisawa-saito, M. et al. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes. Oncogene 26, 2988-2996 (2007).
28. Fan, G. et al. A novel link between REC2, a DNA recombinase, the retinoblastoma protein, and apoptosis. J. Biol. Chem. 272, 19413-19417 (1997).
29. Zur Hausen, H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2, 342-350 (2002).
30. Slebos, R. J. et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin. Cancer Res. 12(3 Pt 1): 701-709 (2006).
31. Pyeon, D. et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67, 4605-4619 (2007).
32. Rosty, C. et al. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene 24, 7094-7104 (2005).
33. Munger, K. et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898 (2001).
34. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
35. McLaughlin-Drubin, M. E. & Munger, K. The human papillomavirus E7 oncoprotein. Virology 384, 335-344 (2009).
36. Rickman, D. S. et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 27, 6607-6622 (2008).
37. Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V. & Sarig, R. p53 is balancing development, differentiation and de-Differentiation to assure cancer prevention. Carcinogenesis 31, 1501-1508 (2010).
38. Peter, M. et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J. Pathol. 221, 320-330 (2010).
39. Rozenblatt-rosen, O. et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487, 491-495 (2012).
40. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
41. Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863-864 (2011).
42. Luo, R. et al. SOAPdenovo2: An empirically improved memory-efficient shortread De novo assembler. GigaScience 1, 18 (2012).
43. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
44. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789 (2012).
45. Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: Fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
46. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440-9445 (2003).
47. Futreal, P. A. et al. A census of human cancer genes. Nat. Rev. Cancer. 4, 177-183 (2004).